The Human Microbiome and Its Impact on Rheumatic and Neurological Diseases
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 4430
Special Issue Editors
Interests: autoimmune disease; inflammation; innate immunity; adaptive immunity
Interests: Parkinson’s disease drug development; Alzheimer's disease drug screening; neurodegenerative diseases model development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Rheumatoid arthritis (RA) is a chronic autoimmune disease triggered by the loss of immunological tolerance to self-antigens, which can cause systemic or organ specific damage. Genetic and environmental factors are the main players involved in the pathogenesis of RA. Abundant evidence suggests that the gut microbiota may be involved in the initiation and amplification of disease progression in patients with RA, neurodegenerative diseases and cancer as well. The possible mechanisms include molecular mimicry, impacts on intestinal mucosa permeability, the host immune response caused by the microbiota, and antigenic mimicry. Gut microbiome has often been investigated with regards to his role in gut-related diseases. However, an emerging role as potential triggering/protective mechanism in chronic diseases and autoimmunity development is currently being studied. Understanding how the gut microbiome composition differs in populations, particularly those with significantly different diets, could unveil potential connection with a higher, or lower, incidence of RA.
Dr. Marco Bo
Dr. Giuseppe Uras
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut
- microbiota
- autoimmunity
- antigens
- arthritis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.